BiVACOR: Funding, Investors & Team (Oct 2026)
In 2008, BiVACOR came into existence as a company that is not publicly traded. Its team is composed of outstanding engineers, medical experts, and business leaders who are committed to pushing forward this innovative technology. They have built a robust partnership network that spans across the world. BiVACOR's main headquarters are situated in Houston, Texas, while their foreign office is set up in Brisbane, Australia.
BiVACOR has raised $50.0M across 3 funding rounds on record, the most recent an undisclosed round of $13.0M announced in Feb 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BiVACOR Company Profile and Key Stats
Latest funding round on record: Feb 2024.
BiVACOR Funding Rounds
BiVACOR raised $19.0M in an undisclosed round announced in May 2021.
1.8 years later, a Series B of $18.0M was announced in Mar 2023.
11 months later, an undisclosed round of $13.0M was announced in Feb 2024.
BiVACOR Founders and Leadership Team
Contact details for the BiVACOR team: 1 of 1 has an email address on file.
Start 14-day free trial →BiVACOR Funding Compared to Other Biotechnology Startups
BiVACOR's latest round of $13.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BiVACOR in Biotechnology and Houston
Companies Similar to BiVACOR
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BiVACOR Funding FAQs
What does BiVACOR do?
In 2008, BiVACOR came into existence as a company that is not publicly traded. Its team is composed of outstanding engineers, medical experts, and business leaders who are committed to pushing forward this innovative technology. They have built a robust partnership network that spans across the world. BiVACOR's main headquarters are situated in Houston, Texas, while their foreign office is set up in Brisbane, Australia.
How much funding has BiVACOR raised?
BiVACOR has raised $50.0M across 3 rounds on record. The most recent is an undisclosed round of $13.0M announced in Feb 2024.
When did BiVACOR last raise funding?
BiVACOR's most recent funding round on record is an undisclosed round of $13.0M, announced in Feb 2024.
Who founded BiVACOR?
FundedIQ lists Daniel Timms (Founder) at BiVACOR.
Where is BiVACOR headquartered?
BiVACOR is based in Houston, Texas, United States.
How many employees does BiVACOR have?
BiVACOR is in the 11-50 employee band.
How does BiVACOR's funding compare to other Biotechnology startups?
BiVACOR's latest round of $13.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BiVACOR Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BiVACOR is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.